Clinical trial Recruiting at 2 sites Interventional Ages 18 to 85

ESPB vs SPSIPB for better recovery after VATS

Official title: Comparison of Ultrasound-Guided Erector Spinae Plane Block and Serratus Posterior Superior Intercostal Plane Block for Quality of Recovery After Video-Assisted Thoracoscopic Surgery: A Randomized Double-Blind Trial

Run by Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital · NCT07729488 · Data updated 2026-11-12

This study tests whether an erector spinae plane block or a serratus posterior superior intercostal plane block improves recovery after video-assisted thoracoscopic surgery.

Quick facts

Study typeInterventional
Ages18 Years to 85 Years
SexAll
Enrollment128 (estimated)
SponsorSaglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Academic / other
Locations2 sites (Diyarbakır, Outside of the US and 1 other locations)
StatusRecruiting
StartedSeptember 16, 2026
Main results expectedDecember 29, 2026
Study endsDecember 30, 2026
Registry record updatedSeptember 21, 2026
Trial IDNCT07729488 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–85 years scheduled for elective VATS under general anesthesia, ASA I–III, able to complete QoR-15, and without contraindications to regional anesthesia or the study drugs.

Probably not a fit

Patients with failed blocks, conversion to thoracotomy, or conditions preventing QoR-15 completion may not experience the anticipated benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, double-blind trial compares two ultrasound-guided regional anesthesia techniques—erector spinae plane block (ESPB) and serratus posterior superior intercostal plane block (SPSIPB)—in adults undergoing elective VATS. The primary outcome is the quality of recovery at 24 hours, measured by QoR-15. Secondary outcomes include pain scores, opioid consumption, time to rescue analgesia, nausea and vomiting, satisfaction, hospital stay, block safety, and perioperative hemodynamics. The study plans to enroll 128 patients and is conducted at a Turkish university hospital with a single lead sponsor. Participants are adults 18–70 (up to 85 in eligibility), ASA I–III, without contraindications to regional anesthesia or opioid analgesics, and able to complete QoR-15.

Why it matters

Potential benefit: If successful, this trial could identify the regional block that provides better early recovery and comfort after VATS, guiding analgesia planning.

How similar studies have gone: Prior studies show promising analgesic effects for both blocks in thoracic surgery, but direct comparative evidence on QoR-15 recovery remains limited, making this trial meaningful.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18-85 years.
* ASA physical status I-III.
* Scheduled for elective VATS under general anesthesia.
* Able to understand and complete the QoR-15 questionnaire.
* Written informed consent provided.

Exclusion Criteria:

* Refusal to participate or inability to provide written informed consent.
* Known allergy or contraindication to bupivacaine, paracetamol, dexketoprofen, or tramadol.
* Infection at the planned block injection site.
* Coagulopathy or ongoing anticoagulant therapy precluding regional anesthesia.
* Severe hepatic or renal insufficiency.
* Chronic opioid use or chronic pain requiring regular analgesic treatment.
* Previous thoracic surgery on the operative side.
* Pregnancy or breastfeeding.
* Cognitive impairment, psychiatric illness, or language barrier preventing completion of the QoR-15 questionnaire.
* Body mass index (BMI) \>35 kg/m².
* Conversion from VATS to thoracotomy.
* Failed or incomplete regional block.

Where it's running

  • Fatma Acil
    Diyarbakır, Outside of the US, Turkey (Türkiye)
    Recruiting
  • Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
    Diyarbakır, Turkey, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: Fatma Acil, M.D. — Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
  • Study coordinator: Fatma Acil, M.D.
  • Email: acilfatma@gmail.com
  • Phone: +905337225225

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.